Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6840)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 21, 2024 (publication date) through Dec 26, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| He QJ, Li YF, Zhao LT, Lin CT, Yu CY, Wang D. Recent advances in age-related metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2024; 30(7): 652-662 [PMID: 38515956 DOI: 10.3748/wjg.v30.i7.652] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | He QJ, Li YF, Zhao LT, Lin CT, Yu CY, Wang D. Recent advances in age-related metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2024; 30(7): 652-662 [PMID: 38515956 DOI: 10.3748/wjg.v30.i7.652] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i7/652.htm |
| Number | Citing Articles |
| 1 |
Julia Markowska, Kamila Kasprzak-Drozd, Przemysław Niziński, Magdalena Dragan, Adrianna Kondracka, Ewa Gondek, Tomasz Oniszczuk, Anna Oniszczuk. Quercetin: A Promising Candidate for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Molecules 2024; 29(22): 5245 doi: 10.3390/molecules29225245
|
| 2 |
Ludovico Abenavoli, Giuseppe Guido Maria Scarlata, Massimo Borelli, Evelina Suraci, Raffaella Marasco, Maria Imeneo, Rocco Spagnuolo, Francesco Luzza. Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases. Journal of Clinical Medicine 2025; 14(9): 2973 doi: 10.3390/jcm14092973
|
| 3 |
Olga Sukocheva, Tsai-Wing Ow, Damian Harding, Marc Le Mire, Edmund Tse. Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives. World Journal of Hepatology 2025; 17(7): 106675 doi: 10.4254/wjh.v17.i7.106675
|
| 4 |
Richard Sprenger, Kat Kiilerich, Mikael Palner, Arsênio Oliveira, Mikaël Croyal, Marie Ostenfeld, Ann Bjørnshave, Gitte Knudsen, Christer Ejsing. Dietary Intake of a Milk Sphingolipid-Rich MFGM/EV Concentrate Ameliorates Age-Related Metabolic Dysfunction. Nutrients 2025; 17(15): 2529 doi: 10.3390/nu17152529
|
| 5 |
Agnieszka Ziółkiewicz, Przemysław Niziński, Jakub Soja, Tomasz Oniszczuk, Maciej Combrzyński, Adrianna Kondracka, Anna Oniszczuk. Potential of Chlorogenic Acid in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Animal Studies and Clinical Trials—A Narrative Review. Metabolites 2024; 14(6): 346 doi: 10.3390/metabo14060346
|
| 6 |
David G. Le Couteur, Meng C. Ngu, Nicholas J. Hunt, Amanda E. Brandon, Stephen J. Simpson, Victoria C. Cogger. Liver, ageing and disease. Nature Reviews Gastroenterology & Hepatology 2025; 22(10): 680 doi: 10.1038/s41575-025-01099-z
|
| 7 |
Ren Yoshitomi, Rajeswari Nanda, Kazumi Hirano, Sunil C. Kaul, Jaspreet Kaur Dhanjal, Renu Wadhwa. Ashwagandha withanolides, Withaferin-A, and Withanone for natural interventions in aging and obesity. Mechanisms of Ageing and Development 2025; 228: 112126 doi: 10.1016/j.mad.2025.112126
|
| 8 |
Bicheng Ye, Yuming Teng, Qianqian Chen, Jie Zhang, Shun Li, Li Dong, Changan Xu, Xiao Qiao, Xiaye Miao. Harnessing machine learning for the development, validation, and prognostic evaluation of MASHRisk score: insights from a multicohort study. npj Digital Medicine 2025; doi: 10.1038/s41746-025-02220-x
|
| 9 |
Jiaxin Zhao, Huiying Zhou, Rui Wu, Chen Ruan, Cheng Wang, Jiawei Ding, Tao Zhang, Zheyu Fang, Huilin Zheng, Lei Zhang, Jie Zhou, Zhenhua Hu. Biological aging accelerates hepatic fibrosis: Insights from the NHANES 2017–2020 and genome-wide association study analysis. Annals of Hepatology 2025; 30(2): 101579 doi: 10.1016/j.aohep.2024.101579
|
| 10 |
Barnabas Horvath, Judit Halasz, Norman Noel Tanner, Zoltan Marton Kohler, Gyorgy Trencsenyi, Laszlo Juhasz, Laszlo Rovo, Andras Kiss, Aniko Keller-Pinter. Tilorone attenuates high-fat diet-induced hepatic steatosis by enhancing BMP9-Smad1/5/8 signaling. GeroScience 2025; doi: 10.1007/s11357-025-01685-8
|
| 11 |
Min Wu, Yifeng Li, Dong Liu, Weinong Wen, Yan Min, Qiang Su, Zhenxiang An, Xiaofang Yang. Time trends and health inequalities of cirrhosis caused by metabolic Dysfunction-associated steatotic liver disease from 1990 to 2021: A global burden of disease study. Journal of Endocrinological Investigation 2025; 48(11): 2599 doi: 10.1007/s40618-025-02631-3
|
| 12 |
Alexis B. Cruickshank-Taylor, Jacob S. Kozora, Jennifer S. Carew, Steffan T. Nawrocki, Wei Wang. Proteolysis targeting chimeras as senolytics: An emerging senotherapy for combating aging. The Journal of Pharmacology and Experimental Therapeutics 2025; 392(11): 103752 doi: 10.1016/j.jpet.2025.103752
|
| 13 |
Ilaria Milani, Maria Eugenia Parrotta, Luca Colangeli, Marianna Chinucci, Simonetta Palleschi, Barbara Rossi, Paolo Sbraccia, Alessandro Mantovani, Frida Leonetti, Valeria Guglielmi, Danila Capoccia. Sex Differences in MASLD After Age 50: Presentation, Diagnosis, and Clinical Implications. Biomedicines 2025; 13(9): 2292 doi: 10.3390/biomedicines13092292
|
| 14 |
А.А. Antoniv, L.V. Kanovska, O.V. Kaushanska, Yu.M. Yarinich. Metabolic dysfunction-associated steatotic liver disease: epidemiological trends, risk factors, and the role of gut microbiota in disease progression (a literature review). INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2025; 21(6): 656 doi: 10.22141/2224-0721.21.6.2025.1627
|
| 15 |
Feng Zhu, Bing-Ru Lin, Shi-Hua Lin, Chao-Hui Yu, Yun-Mei Yang. Hepatic-specific vitamin D receptor downregulation alleviates aging-related metabolic dysfunction-associated steatotic liver disease. World Journal of Gastroenterology 2025; 31(14): 104117 doi: 10.3748/wjg.v31.i14.104117
Abstract(384) |
Core Tip(343) |
Full Article(HTML)(1502)
|
Full Article with Cover (PDF)-34957K(128)
|
Audio-192K(27)
|
Peer-Review Report-228K(55)
|
Answering Reviewers-442K(60)
|
Supplementary Material-562K(69)
|
Full Article (PDF)-34673K(144)
|
Full Article (XML)-144K(72)
|
Times Cited (2)
|
Total Visits (4278)
|
Open
|
| 16 |
Stavros P. Papadakos, Chara Georgiadou, Eva Kassi, Rallia-Iliana Velliou, Antonios Chatzigeorgiou. Animal models of lean metabolic dysfunction-associated steatotic liver disease (MASLD): bridging pathogenesis and novel drug discovery. Expert Opinion on Drug Discovery 2025; : 1 doi: 10.1080/17460441.2025.2579124
|
| 17 |
Xingyu Yuan, Yifeng Hou, Narisu Qin, Lu Xiang, Zhe Jiang, Xiaolan Bao. Flaxseed-derived peptide, Ile-Pro-Pro-Phe (IPPF), ameliorates hepatic cholesterol metabolism to treat metabolic dysfunction-associated steatotic liver disease by promoting cholesterol conversion and excretion. Food & Function 2025; 16(7): 2808 doi: 10.1039/D4FO04478A
|
| 18 |
Vu Thuong Huyen, Kanae Echizen, Ryota Yamagishi, Miho Kumagai, Yoshiki Nonaka, Takahiro Kodama, Tatsuya Ando, Megumu Yano, Naoki Takada, Masaki Takasugi, Fumitaka Kamachi, Naoko Ohtani. Regular exercise suppresses steatosis‐associated liver cancer development by degrading E2F1 and c‐Myc via circadian gene upregulation. Genes to Cells 2024; 29(11): 1012 doi: 10.1111/gtc.13161
|
| 19 |
Dmytro Kryvozub, Tetiana Riabenko, Alina Ponyrko. AGE-RELATED FEATURES OF LIVER CHANGES DURING INTERMITTENT FASTING (LITERATURE REVIEW). Eastern Ukrainian Medical Journal 2025; 13(2): 352 doi: 10.21272/eumj.2025;13(2):352-363
|
| 20 |
Tamer A. Addissouky. Molecular insights into herbal medicines for the treatment of metabolic associated Steatohepatitis. Discover Chemistry 2025; 2(1) doi: 10.1007/s44371-025-00212-0
|
| 21 |
Diya Tawk, Ghalia Ghader, Yasmina Khatib, Philippe Attieh, Tya Youssef, Mahmoud Othman, Frederic Harb, Sami Azar, Hilda E. Ghadieh. Nutritional and Fasting Strategies for the Management of MASLD/MASH: An Integrative Review. JGH Open 2025; 9(12) doi: 10.1002/jgh3.70315
|